Thanou A - Search Results

1

The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials.

Merrill JT, Immermann F, Whitley M, Zhou T, Hill A, O'Toole M, Reddy P, Honczarenko M, Thanou A, Rawdon J, Guthridge JM, James JA, Sridharan S. Merrill JT, et al. Among authors: thanou a. Arthritis Rheumatol. 2017 Jun;69(6):1257-1266. doi: 10.1002/art.40086. Arthritis Rheumatol. 2017. PMID: 28257602 Free PMC article.

2

Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys.

Thanou A, Merrill JT. Thanou A, et al. Nat Rev Rheumatol. 2014 Jan;10(1):23-34. doi: 10.1038/nrrheum.2013.145. Epub 2013 Oct 8. Nat Rev Rheumatol. 2014. PMID: 24100460 Review.

3

How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index.

Thanou A, Chakravarty E, James JA, Merrill JT. Thanou A, et al. Rheumatology (Oxford). 2014 Dec;53(12):2175-81. doi: 10.1093/rheumatology/keu153. Epub 2014 Apr 11. Rheumatology (Oxford). 2014. PMID: 24729400 Free PMC article.

4

Impact of heart rate variability, a marker for cardiac health, on lupus disease activity.

Thanou A, Stavrakis S, Dyer JW, Munroe ME, James JA, Merrill JT. Thanou A, et al. Arthritis Res Ther. 2016 Sep 2;18(1):197. doi: 10.1186/s13075-016-1087-x. Arthritis Res Ther. 2016. PMID: 27590046 Free PMC article.

5

New Trials in Lupus and where Are we Going.

Thanou A, Merrill JT. Thanou A, et al. Curr Rheumatol Rep. 2018 May 3;20(6):34. doi: 10.1007/s11926-018-0745-1. Curr Rheumatol Rep. 2018. PMID: 29725880 Review.

6

Top 10 things to know about lupus activity measures.

Thanou A, Merrill JT. Thanou A, et al. Curr Rheumatol Rep. 2013 Jun;15(6):334. doi: 10.1007/s11926-013-0334-2. Curr Rheumatol Rep. 2013. PMID: 23606072 Review.

7

Which outcome measures in SLE clinical trials best reflect medical judgment?

Thanou A, Chakravarty E, James JA, Merrill JT. Thanou A, et al. Lupus Sci Med. 2014 Apr 1;1(1):e000005. doi: 10.1136/lupus-2013-000005. eCollection 2014. Lupus Sci Med. 2014. PMID: 25396057 Free PMC article.

8

Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study.

Guthridge JM, Lu R, Tran LT, Arriens C, Aberle T, Kamp S, Munroe ME, Dominguez N, Gross T, DeJager W, Macwana SR, Bourn RL, Apel S, Thanou A, Chen H, Chakravarty EF, Merrill JT, James JA. Guthridge JM, et al. Among authors: thanou a. EClinicalMedicine. 2020 Mar 4;20:100291. doi: 10.1016/j.eclinm.2020.100291. eCollection 2020 Mar. EClinicalMedicine. 2020. PMID: 32154507 Free PMC article.

9

Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures.

Thanou A, James JA, Arriens C, Aberle T, Chakravarty E, Rawdon J, Stavrakis S, Merrill JT, Askanase A. Thanou A, et al. Lupus Sci Med. 2019 Dec 30;6(1):e000365. doi: 10.1136/lupus-2019-000365. eCollection 2019. Lupus Sci Med. 2019. PMID: 31921432 Free PMC article.

10

Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers.

Arriens C, Aberle T, Carthen F, Kamp S, Thanou A, Chakravarty E, James JA, Merrill JT, Ogunsanya ME. Arriens C, et al. Among authors: thanou a. Lupus Sci Med. 2020 Mar 15;7(1):e000360. doi: 10.1136/lupus-2019-000360. eCollection 2020. Lupus Sci Med. 2020. PMID: 32201595 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters